Fmoc-FF Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells
Pharmaceutics · 17.02.2025 · 17 (2) · 263
DOI: 10.3390/pharmaceutics17020263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 17.02.2025. Verfasst von Enrico Gallo und 7 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS SYNLAB SDN, 80146 Naples, Italy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Ministero dell'università e della ricerca, Italian Ministry of Health.
Abstract (Originalsprache)
Background
Thyroid cancer (TC) is the most prevalent endocrine malignancy, and is categorized into well-differentiated and aggressive anaplastic types. Novel therapeutic modalities are needed for TC. Nanomedicine is a promising strategy for the development of precision medicine. In this context, we investigated the use of nanogels (NGs) to deliver agents with different physicochemical properties, specifically the hydrophilic agent doxorubicin (DOX) and the hydrophobic compound curcumin (CUR), in TC cell lines.
Methods
Nα-9-fluorenylmethoxycarbonyl-diphenylalanine (Fmoc-FF) peptide-based NGs loaded with DOX and CUR were formulated using the solvent-switch method. DOX-loaded NGs were previously characterized. CUR-loaded NGs were characterized through rheology, scanning electron microscopy (SEM), dynamic light scattering (DLS), nanoparticle tracking analysis (NTA), and Fourier transform infrared (FT-IR) spectroscopy. Confocal microscopy, q-RT-PCR, and ATP lite assays were performed to evaluate the uptake and delivery of DOX- and CUR-loaded NGs on TC cell lines.
Results
CUR-loaded NGs exhibited a mean diameter of approximately 204.3 nm and a zeta potential of −34.6 mV, indicative of a good stability. In vitro release studies revealed a sustained release profile of CUR over 72 h. Functional analyses demonstrated that Fmoc-FF-loaded NGs were internalized into TC cell lines. They were primarily localized in the cytoplasm rather than in early endosomes, thereby ensuring intracellular stability. Furthermore, Fmoc-FF NGs reduced the nuclear uptake kinetics of DOX in TC cells, suggesting a potential reduction in dose-limiting toxicity. Comparative studies with CUR-loaded NGs revealed similar internalization and delayed nuclear uptake, highlighting the efficacy of Fmoc-FF NGs in delivering hydrophobic agents.
Conclusions
Overall, the data suggest that Fmoc-FF NGs represent a promising strategy for delivering agents with diverse physicochemical properties in TC, enhancing their efficacy and safety and warranting further investigation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IRCCS SYNLAB SDN, 80146 Naples, Italy.
- Dipartimento delle Scienze Mediche, Motorie e del Benessere, Università degli Studi di Napoli "Parthenope", 80133 Naples, Italy.
- CEINGE-Biotecnologie Avanzate Franco Salvatore, 80131 Naples, Italy.
- Dipartimento di Scienze Biomediche Avanzate, Università degli Studi di Napoli "Federico II", 80131 Naples, Italy.
- Dipartimento di Farmacia, Università degli Studi di Napoli "Federico II", 80131 Naples, Italy.
ORCID-Profile: Enrico Gallo, Giovanni Smaldone, Mariantonia Braile, Neila Luciano, Antonella Accardo
Förderung
- Ministero della Salute
- Ministero dell'università e della ricerca
- Italian Ministry of Health
- MUR
Zitieren
APA
Gallo, E., Smaldone, G., Cimmino, L., Braile, M., Orlandella, F. M., Luciano, N., Accardo, A., & Salvatore, G. (2025). Fmoc-FF Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells. Pharmaceutics, 17(2), 263. https://doi.org/10.3390/pharmaceutics17020263
Vancouver
Gallo E, Smaldone G, Cimmino L, Braile M, Orlandella FM, Luciano N, et al. Fmoc-FF Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells. Pharmaceutics. 2025;17(2):263. doi:10.3390/pharmaceutics17020263
BibTeX
@article{Gallo2025,
author = {Gallo, Enrico and Smaldone, Giovanni and Cimmino, Luca and Braile, Mariantonia and Orlandella, Francesca Maria and Luciano, Neila and Accardo, Antonella and Salvatore, Giuliana},
title = {Fmoc-FF Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {2},
pages = {263},
doi = {10.3390/pharmaceutics17020263}
}
EUVIMED